- Home
- LIPO vs RELI Comparison
LIPO vs RELI Comparison
Compare LIPO & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIPO
- RELI
- Stock Information
- Founded
- LIPO 2005
- RELI 2013
- Country
- LIPO United States
- RELI United States
- Employees
- LIPO N/A
- RELI N/A
- Industry
- LIPO Biotechnology: Pharmaceutical Preparations
- RELI Specialty Insurers
- Sector
- LIPO Health Care
- RELI Finance
- Exchange
- LIPO Nasdaq
- RELI Nasdaq
- Market Cap
- LIPO 3.8M
- RELI 3.3M
- IPO Year
- LIPO 2022
- RELI N/A
- Fundamental
- Price
- LIPO $2.85
- RELI $2.14
- Analyst Decision
- LIPO Strong Buy
- RELI Strong Buy
- Analyst Count
- LIPO 1
- RELI 1
- Target Price
- LIPO $16.00
- RELI $119.00
- AVG Volume (30 Days)
- LIPO 91.5K
- RELI 5.6M
- Earning Date
- LIPO 02-25-2025
- RELI 11-07-2024
- Dividend Yield
- LIPO N/A
- RELI N/A
- EPS Growth
- LIPO N/A
- RELI N/A
- EPS
- LIPO N/A
- RELI N/A
- Revenue
- LIPO $483,533.00
- RELI $14,078,473.00
- Revenue This Year
- LIPO N/A
- RELI N/A
- Revenue Next Year
- LIPO N/A
- RELI N/A
- P/E Ratio
- LIPO N/A
- RELI N/A
- Revenue Growth
- LIPO 0.78
- RELI 4.71
- 52 Week Low
- LIPO $2.21
- RELI $1.18
- 52 Week High
- LIPO $12.00
- RELI $18.53
- Technical
- Relative Strength Index (RSI)
- LIPO 45.72
- RELI 49.98
- Support Level
- LIPO $2.78
- RELI $1.73
- Resistance Level
- LIPO $3.17
- RELI $2.50
- Average True Range (ATR)
- LIPO 0.29
- RELI 0.41
- MACD
- LIPO -0.04
- RELI -0.07
- Stochastic Oscillator
- LIPO 7.61
- RELI 27.33
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
About RELI Reliance Global Group Inc.
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing an acquisition strategy, initially and primarily focused on wholesale and retail insurance agencies. Its primary strategy is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.